A Clinical Trial to study the effectiveness of Homoeopathy as an additional mode of treatment in combating Corona Virus infection

Effectiveness of Homoeopathy as an ancillary mode of treatment and management in combating Corona Virus infection - A Randomized, placebo-controlled, Single Blind Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/04/024905

Enrollment

100

Registered

2020-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J80- Acute respiratory distress syndrome Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 3: R05- Cough Health Condition 4: R060- Dyspnea Health Condition 5: R509- Fever, unspecified Health Condition 6: R068- Other abnormalities of breathing Health Condition 7: J128- Other viral pneumonia

Interventions

Intervention1: Homoeopathic Medicine: Arsenic Album, Bryonia Alba, Gelsemium, Antimonium Tartaricum, Crotalus Horridus: 100 ml water with 1 drop of indicated Homoeopathic Medicine in 30/ 200/ 1M poten

Eligibility

Inclusion criteria

Inclusion criteria: •Patients suffering from COVID-19 along with subjective and objective symptoms. •Patients with age groups of 5-70 years. •Patients of both genders. •Patients who are willing to give informed consent.

Exclusion criteria

Exclusion criteria: •More than 70 years of age and less than age of 5 years. •Pregnant females and lactating females. •Subjects considered not suitable for the study by the researchers.

Design outcomes

Primary

Measure	Time frame
Primary outcome of this trial will be measured in terms of clinically recovered case (Covid-19 negative) or death.Timepoint: 21 days	—

Secondary

Measure	Time frame
Decrease in the frequency of the dosage of drugs of modern medicine/ conventional treatment according to the standard treatment protocol.Timepoint: 3 days;Decrease in the usage of life supportive equipment like ventilator usage, etcTimepoint: 5 days;Improvement in the quality of life including virulent symptoms of the patientsTimepoint: 24 hours;Recovery in the case where patient is experiencing severe acute respiratory syndromeTimepoint: 2 hours	—

Measure

Time frame

Decrease in the frequency of the dosage of drugs of modern medicine/ conventional treatment according to the standard treatment protocol.Timepoint: 3 days;Decrease in the usage of life supportive equipment like ventilator usage, etcTimepoint: 5 days;Improvement in the quality of life including virulent symptoms of the patientsTimepoint: 24 hours;Recovery in the case where patient is experiencing severe acute respiratory syndromeTimepoint: 2 hours

—

Countries

India

Contacts

Public ContactDr Shaurabh Kumar

Naiminath Homoeopathic Medical College, Hospital and Research Centre

deepeshg1@gmail.com8193896315

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026